← All indications
Prostatic Hyperplasia
Increase in constituent cells in the PROSTATE, leading to enlargement of the organ (hypertrophy) and adverse impact on the lower urinary tract function. This can be caused by increased rate of cell proliferation, reduced rate of cell death, or both.
Drugs by status
Approved for this indication (11)
Phase 4 trials (25)
- nitrous oxide
- desmopressin
- mirabegron
- ibuprofen
- alpha-1 antitrypsin
- nalbuphine
- atorvastatin
- prazosin
- celecoxib
- sulfamethoxazole
- tolterodine
- testosterone
- ciprofloxacin
- prunus domestica
- pyridostigmine bromide
- tranexamic acid
- oxygen
- solifenacin
- cephalexin
- nitrofurantoin
- trimethoprim
- methoxyflurane
- quinapril
- dexamethasone
- abobotulinumtoxinA
Phase 3 trials (20)
Phase 2 trials (25)
Phase 1 trials (12)
Organizations
Organization Involved with Phase 4 Indications (49)
- Pierre Fabre
- Astellas
- Recordati
- Sanofi
- Bioforce AG
- Dong-A Pharmaceutical
- Handok Pharmaceuticals Co., Ltd.
- JW Pharmaceutical
- Solvay
- Boehringer Ingelheim
- Siami, Paul F., M.D.
- Chungbuk National University
- University of London
- University of Washington
- I.M. Sechenov First Moscow State Medical University
- Inje University
- Korea University
- Kocatepe University
- Mansoura University
- McMaster University
- Seoul National University
- Sheffield Hallam University
- University of Florence
- Urologic Consultants of Southeastern PA
- Chonbuk National University
- Istanbul Medeniyet University
- University of Copenhagen
- University of Ulsan
- Bangladesh Medical University
- University of Ankara
- +19 more
Organization Involved with Phase 3 Indications (54)
- Spectrum Pharmaceuticals
- AEterna Zentaris
- ICOS
- GL Pharm Tech Corporation
- Health Ever Bio-Tech Co., Ltd.
- Jeil Pharmaceutical Co., Ltd.
- Materia Medica Holding
- Nymox Corporation
- Sophiris Bio Corp
- Threshold Pharmaceuticals
- Chong Kun Dang Pharmaceutical
- IlDong Pharmaceutical Co Ltd
- Vantia Ltd
- National Center for Complementary and Integrative Health (NCCIH)
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- United States Army
- Baylor University
- Emory University
- Hanyang University
- Henry Ford Health System
- Kaiser Permanente
- New York University
- Northwestern University
- Queen's University, Belfast
- University of Iowa
- University of Maryland
- University of Rochester
- University of Alberta
- University of Bordeaux
- Yale University
- +24 more
Organization Involved with Phase 2 Indications (29)
- Novelion Therapeutics
- Takeda
- Allergan
- American Medical Systems
- Bayer
- Kissei Pharmaceuticals
- Kael-GemVax Co., Ltd.
- Light Sciences Oncology
- Milkhaus Laboratory
- Mundipharma
- innoVactiv Inc.
- Ausio Pharmaceuticals, LLC
- Transition Therapeutics
- National Cancer Institute (NCI)
- Warner Chilcott
- Benha University
- Tzu Chi University
- Central Clinical Hospital with Outpatient Health Center of Business Administration for the President of Russian Federati
- Georgetown University
- McGill University
- University of South Florida
- Kwame Nkrumah University of Science and Technology
- Taipei Veteran General hospital
- Government of Russia
- Tampa Bay Medical Research
- CanMed Clinical Research Inc.
- Ferring
- Dongguk University
- Urotronic Inc.
Organization Involved with Phase 1 Indications (18)
- BTG
- Dongkook Pharmaceutical Co., Ltd.
- Parexel
- Yuyu Pharma, Inc.
- AIDS Malignancy Consortium
- Dong-A University
- Manchanda Medical Clinic
- Yonsei University
- University of California, Irvine
- Beni Suef University
- Boryung Pharmaceutical Company
- Cha Medical University
- University of Texas at Houston
- University of North Carolina at Chapel Hill
- Pomegranate Health
- Jarrow Pharmaceuticals
- Bestian Hospital
- Embolx, Inc.
Organization Involved with Other Experimental Indications (14)
- Applied Biology, Inc.
- Franklin D. Gaylis, MD Inc.
- Harvard University
- Kaohsiung Medical University
- Medical College of Wisconsin
- Saint-Joseph University
- University of Pavia
- Urology of Virginia
- Chinese University of Hong Kong
- Golden Biotechnology Corp.
- University of Sao Paulo
- University of Illinois at Chicago
- Government of Hong Kong
- Corpometria Institute